Unveiling the intricacies of phytate antinutrients in millets and their therapeutic implications in breast cancer.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 4, p. 516, doi. 10.1016/j.ipha.2023.12.005
- By:
- Publication type:
- Article
Works matching IS 2949866X AND DT 2024 AND VI 2 AND IP 4
Results: 14
1
2
The importance of in-silico studies in drug discovery.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 4, p. 578, doi. 10.1016/j.ipha.2024.01.010
- By:
- Publication type:
- Article
3
The fermented milk can be a natural ally against obesity? Investigation of bovine milk fermentation by Lacticaseibacillus casei LBC 237, screening, and In silico predictions of bioactive peptides for obesity control.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 4, p. 467, doi. 10.1016/j.ipha.2024.05.009
- By:
- Publication type:
- Article
4
Telmisartan-loaded liposomes: An innovative weapon against breast cancer.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 4, p. 565, doi. 10.1016/j.ipha.2024.01.001
- By:
- Publication type:
- Article
5
Rosmarinic acid: Potential antiviral agent against dengue virus - In silico evaluation.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 4, p. 528, doi. 10.1016/j.ipha.2023.12.006
- By:
- Publication type:
- Article
6
QSAR application of natural therapeutics inhibitors against Alzheimer's disease through in-silico virtual-screening, docking-simulation, molecular dynamics, and pharmacokinetic prediction analysis.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 4, p. 505, doi. 10.1016/j.ipha.2023.12.004
- By:
- Publication type:
- Article
7
Nutritional composition, antioxidant properties, and molecular docking strategy of muricidae operculum (Chicoreus ramosus).
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 4, p. 485, doi. 10.1016/j.ipha.2023.11.006
- By:
- Publication type:
- Article
8
In-silico screening and ADMET evaluation of therapeutic MAO-B inhibitors against Parkinson disease.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 4, p. 554, doi. 10.1016/j.ipha.2023.12.008
- By:
- Publication type:
- Article
9
In-silico design of novel 2-((4-chloro-6-methoxy-1H-indol-3-yl) thio)-N-(2-ethoxyphenyl)acetamide derivatives as potential inhibitors of influenza neuraminidase protein receptor.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 4, p. 495, doi. 10.1016/j.ipha.2023.12.002
- By:
- Publication type:
- Article
10
Bioactive peptides derived from the enzymatic hydrolysis of cowhide collagen for the potential treatment of atherosclerosis: A computational approach.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 4, p. 456, doi. 10.1016/j.ipha.2024.05.004
- By:
- Publication type:
- Article
11
Association of immunomodulatory therapies with COVID-19 mortality in rheumatoid arthritis: An analysis of the FDA adverse event reporting system.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 4, p. 451, doi. 10.1016/j.ipha.2024.05.003
- By:
- Publication type:
- Article
12
Antimicrobial screening and molecular docking of synthesized 4,6-di(1H-indol-3-yl)-1,6-dihydropyrimidin-2-amine.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 4, p. 571, doi. 10.1016/j.ipha.2024.01.002
- By:
- Publication type:
- Article
13
Advancing oral drug delivery: The science of fast dissolving tablets (FDTs).
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 4, p. 580, doi. 10.1016/j.ipha.2024.01.011
- By:
- Publication type:
- Article
14
Acalypha wilkesiana L - A potential anti-stearoyl-CoA desaturase agent: Insilico and network pharmacology studies.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 4, p. 540, doi. 10.1016/j.ipha.2023.12.007
- By:
- Publication type:
- Article